LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5506-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients

Tumor Biology
MedicineCancer Research
2017English

Apolipoprotein C1 (APOC1) as a Novel Diagnostic and Prognostic Biomarker for Lung Cancer: A Marker Phase I Trial

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2014English

Volume-Based Growth Tumor Kinetics as a Prognostic Biomarker for Patients With EGFR Mutant Lung Adenocarcinoma Undergoing EGFR Tyrosine Kinase Inhibitor Therapy: A Case Control Study

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2016English

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Oncology Reports
MedicineCancer ResearchOncology
2014English

2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma

Journal of Clinical and Translational Science
Medicine
2018English

A Case of Small Cell Lung Cancer Transformation From EGFR-Mutant Lung Adenocarcinoma With Primary Resistance to Gefitinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Can We Omit Radiotherapy in Case of Brain Metastases for Patients With Mutant EGFR Lung Adenocarcinoma?

Translational Lung Cancer Research
Oncology
2017English

P3.16-03 Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy